Updates in the Eighth Edition of the Tumor-Node-Metastasis Staging Classification for Urologic Cancers

Amin, 2017 Amin, 2017, The eighth edition AJCC cancer staging manual: continuing to build a bridge from a population-based to a more “personalized” approach to cancer staging, CA Cancer J Clin, 67, 93, 10.3322/caac.21388 Kattan, 2016, American Joint Committee on Cancer acceptance criteria for inclusion of risk models for individualized prognosis in the practice of precision medicine, CA Cancer J Clin, 66, 370, 10.3322/caac.21339 Magi-Galluzzi, 2011, International Society of Urological Pathology (ISUP) Consensus Conference on Handling and Staging of Radical Prostatectomy Specimens. Working group 3: extraprostatic extension, lymphovascular invasion and locally advanced disease, Mod Pathol, 24, 26, 10.1038/modpathol.2010.158 Samaratunga, 2011, International Society of Urological Pathology (ISUP) Consensus Conference on Handling and Staging of Radical Prostatectomy Specimens. Working group 1: specimen handling, Mod Pathol, 24, 6, 10.1038/modpathol.2010.178 Tan, 2011, International Society of Urological Pathology (ISUP) Consensus Conference on Handling and Staging of Radical Prostatectomy Specimens. Working group 5: surgical margins, Mod Pathol, 24, 48, 10.1038/modpathol.2010.155 van der Kwast, 2011, International Society of Urological Pathology (ISUP) Consensus Conference on Handling and Staging of Radical Prostatectomy Specimens. Working group 2: T2 substaging and prostate cancer volume, Mod Pathol, 24, 16, 10.1038/modpathol.2010.156 Berney, 2011, International Society of Urological Pathology (ISUP) Consensus Conference on Handling and Staging of Radical Prostatectomy Specimens. Working group 4: seminal vesicles and lymph nodes, Mod Pathol, 24, 39, 10.1038/modpathol.2010.160 Trpkov, 2013, Handling and staging of renal cell carcinoma: the International Society of Urological Pathology Consensus (ISUP) conference recommendations, Am J Surg Pathol, 37, 1505, 10.1097/PAS.0b013e31829a85d0 Verrill, 2017, Reporting and Staging of Testicular Germ Cell Tumors: The International Society of Urological Pathology (ISUP) Testicular Cancer Consultation Conference Recommendations, Am J Surg Pathol, 41, e22, 10.1097/PAS.0000000000000844 Moch, 2016 CAP Cancer Protocol Templates. Published February 2017. http://www.cap.org. Brierley, 2017 Delahunt, 2017, UICC drops the ball in the 8th edition TNM staging of urological cancers, Histopathology, 71, 5, 10.1111/his.13200 Chaux, 2009, Comparison of morphologic features and outcome of resected recurrent and nonrecurrent squamous cell carcinoma of the penis: a study of 81 cases, Am J Surg Pathol, 33, 1299, 10.1097/PAS.0b013e3181a418ae Sun, 2015, Development and external validation of a prognostic tool for prediction of cancer-specific mortality after complete loco-regional pathological staging for squamous cell carcinoma of the penis, BJU Int, 116, 734, 10.1111/bju.12677 Clark, 2013, Penile cancer: clinical practice guidelines in oncology, J Natl Compr Canc Netw, 11, 594, 10.6004/jnccn.2013.0075 Velazquez, 2008, Histologic grade and perineural invasion are more important than tumor thickness as predictor of nodal metastasis in penile squamous cell carcinoma invading 5 to 10mm, Am J Surg Pathol, 32, 974, 10.1097/PAS.0b013e3181641365 Leijte, 2008, Evaluation of current TNM classification of penile carcinoma, J Urol, 180, 933, 10.1016/j.juro.2008.05.011 Li, 2015, Modification of N staging systems for penile cancer: a more precise prediction of prognosis, Br J Cancer, 113, 1746, 10.1038/bjc.2015.457 Zhu, 2011, New N staging system of penile cancer provides a better reflection of prognosis, J Urol, 186, 518, 10.1016/j.juro.2011.03.104 Hakenberg, 2015, EAU guidelines on penile cancer: 2014 update, Eur Urol, 67, 142, 10.1016/j.eururo.2014.10.017 Li, 2017, Subclassification of pN3 staging systems for penile cancer: Proposal for modification of the current TNM classification, Urol Oncol, 35, 543, 10.1016/j.urolonc.2017.04.009 Thuret, 2011, Tumor grade improves the prognostic ability of American Joint Committee on Cancer stage in patients with penile carcinoma, J Urol, 185, 501, 10.1016/j.juro.2010.09.111 Broders, 1921, Squamous-cell epithelioma of the skin: a study of 256 cases, Ann Surg, 73, 141, 10.1097/00000658-192102000-00001 Slaton, 2001, Tumor stage, vascular invasion and the percentage of poorly differentiated cancer: independent prognosticators for inguinal lymph node metastasis in penile squamous cancer, J Urol, 165, 1138, 10.1016/S0022-5347(05)66450-6 Velazquez, 2005, Sarcomatoid carcinoma of the penis: a clinicopathologic study of 15 cases, Am J Surg Pathol, 29, 1152, 10.1097/01.pas.0000160440.46394.a8 Epstein, 2016, The 2014 International Society of Urological Pathology (ISUP) Consensus Conference on Gleason Grading of Prostatic Carcinoma: definition of grading patterns and proposal for a new grading system, Am J Surg Pathol, 40, 244, 10.1097/PAS.0000000000000530 Epstein, 2017, Contemporary Gleason grading of prostatic carcinoma: an update with discussion on practical issues to implement the 2014 International Society of Urological Pathology (ISUP) Consensus Conference on Gleason Grading of Prostatic Carcinoma, Am J Surg Pathol, 41, e1, 10.1097/PAS.0000000000000820 Epstein, 2016, A contemporary prostate cancer grading system: a validated alternative to the Gleason score, Eur Urol, 69, 428, 10.1016/j.eururo.2015.06.046 Sanda, 2017 2017 de Rooij, 2016, Accuracy of magnetic resonance imaging for local staging of prostate cancer: A diagnostic meta-analysis, Eur Urol, 70, 233, 10.1016/j.eururo.2015.07.029 Kordan, 2009, Pathological stage T2 subgroups to predict biochemical recurrence after prostatectomy, J Urol, 182, 2291, 10.1016/j.juro.2009.07.020 Chun, 2006, The 2002 AJCC pT2 substages confer no prognostic information on the rate of biochemical recurrence after radical prostatectomy, Eur Urol, 49, 273, 10.1016/j.eururo.2005.12.009 Epstein, 2011, Prognostic significance of tumor volume in radical prostatectomy and needle biopsy specimens, J Urol, 186, 790, 10.1016/j.juro.2011.02.2695 Eichelberger, 2004, Does pT2b prostate carcinoma exist? Critical appraisal of the 2002 TNM classification of prostate carcinoma, Cancer, 100, 2573, 10.1002/cncr.20305 Ettel, 2016, Modification of the pT2 substage classification in prostate adenocarcinoma, Hum Pathol, 56, 57, 10.1016/j.humpath.2016.05.016 Buyyounouski, 2017, Prostate cancer—major changes in the American Joint Committee on Cancer eighth edition cancer staging manual, CA Cancer J Clin, 67, 245, 10.3322/caac.21391 Bhindi, 2017, Independent validation of the American Joint Committee on Cancer 8th Edition prostate cancer staging classification, J Urol, 198, 1286, 10.1016/j.juro.2017.06.085 Halabi, 2014, Updated prognostic model for predicting overall survival in first-line chemotherapy for patients with metastatic castration-resistant prostate cancer, J Clin Oncol, 32, 671, 10.1200/JCO.2013.52.3696 Halabi, 2013, Prognostic model predicting metastatic castration-resistant prostate cancer survival in men treated with second-line chemotherapy, J Natl Cancer Inst, 105, 1729, 10.1093/jnci/djt280 Williamson, 2017, The World Health Organization 2016 classification of testicular germ cell tumours: a review and update from the International Society of Urological Pathology Testis Consultation Panel, Histopathology, 70, 335, 10.1111/his.13102 Chung, 2015, Evaluation of a prognostic model for risk of relapse in stage I seminoma surveillance, Cancer Med, 4, 155, 10.1002/cam4.324 Aparicio, 2014, Prognostic factors for relapse in stage I seminoma: a new nomogram derived from three consecutive, risk-adapted studies from the Spanish Germ Cell Cancer Group (SGCCG), Ann Oncol, 25, 2173, 10.1093/annonc/mdu437 Warde, 2002, Prognostic factors for relapse in stage I seminoma managed by surveillance: a pooled analysis, J Clin Oncol, 20, 4448, 10.1200/JCO.2002.01.038 Albers, 2015, Guidelines on Testicular Cancer: 2015 Update, Eur Urol, 68, 1054, 10.1016/j.eururo.2015.07.044 Kamba, 2010, Outcome of different post-orchiectomy management for stage I seminoma: Japanese multi-institutional study including 425 patients, Int J Urol, 17, 980, 10.1111/j.1442-2042.2010.02645.x Vogt, 2010, Rete testis invasion by malignant germ cell tumor and/or intratubular germ cell neoplasia: what is the significance of this finding?, Hum Pathol, 41, 1339, 10.1016/j.humpath.2010.03.005 Yilmaz, 2013, Testicular hilum and vascular invasion predict advanced clinical stage in nonseminomatous germ cell tumors, Mod Pathol, 26, 579, 10.1038/modpathol.2012.189 Berney, 2015, Handling and reporting of orchidectomy specimens with testicular cancer: areas of consensus and variation among 25 experts and 225 European pathologists, Histopathology, 67, 313, 10.1111/his.12657 Bonsib, 2007, Renal veins and venous extension in clear cell renal cell carcinoma, Mod Pathol, 20, 44, 10.1038/modpathol.3800726 Grignon, 2007, Renal cell carcinoma and the renal sinus, Adv Anat Pathol, 14, 63, 10.1097/PAP.0b013e318032452e Delahunt, 2013, The International Society of Urological Pathology (ISUP) grading system for renal cell carcinoma and other prognostic parameters, Am J Surg Pathol, 37, 1490, 10.1097/PAS.0b013e318299f0fb Dagher, 2017, Clear cell renal cell carcinoma: validation of WHO/ISUP grading, Histopathology, 71, 918, 10.1111/his.13311 Przybycin, 2014, Rhabdoid differentiation is associated with aggressive behavior in renal cell carcinoma: a clinicopathologic analysis of 76 cases with clinical follow-up, Am J Surg Pathol, 38, 1260, 10.1097/PAS.0000000000000251 Gokden, 2000, Renal cell carcinoma with rhabdoid features, Am J Surg Pathol, 24, 1329, 10.1097/00000478-200010000-00002 Shannon, 2002, Adult rhabdoid renal cell carcinoma, Arch Pathol Lab Med, 126, 1506, 10.5858/2002-126-1506-ARRCC Leroy, 2007, Renal cell carcinoma with rhabdoid features: an aggressive neoplasm with overexpression of p53, Arch Pathol Lab Med, 131, 102, 10.5858/2007-131-102-RCCWRF Paner, 2017, Challenges in pathologic staging of bladder cancer: proposals for fresh approaches of assessing pathologic stage in light of recent studies and observations pertaining to bladder histoanatomic variances, Adv Anat Pathol, 24, 113, 10.1097/PAP.0000000000000152 Fritsche, 2010, Characteristics and outcomes of patients with clinical T1 grade 3 urothelial carcinoma treated with radical cystectomy: results from an international cohort, Eur Urol, 57, 300, 10.1016/j.eururo.2009.09.024 Shariat, 2007, Discrepancy between clinical and pathologic stage: impact on prognosis after radical cystectomy, Eur Urol, 51, 137, 10.1016/j.eururo.2006.05.021 Babjuk, 2017, EAU Guidelines on Non-muscle-invasive urothelial carcinoma of the bladder: update 2016, Eur Urol, 71, 447, 10.1016/j.eururo.2016.05.041 van der Aa, 2005, A new system for substaging pT1 papillary bladder cancer: a prognostic evaluation, Hum Pathol, 36, 981, 10.1016/j.humpath.2005.06.017 van Rhijn, 2012, A new and highly prognostic system to discern T1 bladder cancer substage, Eur Urol, 61, 378, 10.1016/j.eururo.2011.10.026 Leivo, 2018, Analysis of T1 bladder cancer on biopsy and transurethral resection specimens: comparison and ranking of T1 quantification approaches to predict progression to muscularis propria invasion, Am J Surg Pathol, 42, e1, 10.1097/PAS.0000000000000964 Njinou Ngninkeu, 2003, Transitional cell carcinoma involving the prostate: a clinicopathological retrospective study of 76 cases, J Urol, 169, 149, 10.1016/S0022-5347(05)64056-6 Esrig, 1996, Transitional cell carcinoma involving the prostate with a proposed staging classification for stromal invasion, J Urol, 156, 1071, 10.1016/S0022-5347(01)65705-7 Pagano, 1996, Is stage pT4a (D1) reliable in assessing transitional cell carcinoma involvement of the prostate in patients with a concurrent bladder cancer?. A necessary distinction for contiguous or noncontiguous involvement, J Urol, 155, 244, 10.1016/S0022-5347(01)66605-9 Patel, 2013, Validation of new AJCC exclusion criteria for subepithelial prostatic stromal invasion from pT4a bladder urothelial carcinoma, J Urol, 189, 53, 10.1016/j.juro.2012.09.006 Knoedler, 2014, Urothelial carcinoma involving the prostate: the association of revised tumour stage and coexistent bladder cancer with survival after radical cystectomy, BJU Int, 114, 832, 10.1111/bju.12486 Hansel, 2011, Limited smoothelin expression within the muscularis mucosae: validation in bladder diverticula, Hum Pathol, 42, 1770, 10.1016/j.humpath.2011.02.022 Golijanin, 2003, Carcinoma in a bladder diverticulum: presentation and treatment outcome, J Urol, 170, 1761, 10.1097/01.ju.0000091800.15071.52 Tamas, 2009, Histopathologic features and clinical outcomes in 71 cases of bladder diverticula, Arch Pathol Lab Med, 133, 791, 10.5858/133.5.791 Hu, 2015, Urothelial carcinoma in bladder diverticula: outcomes after radical cystectomy, World J Urol, 33, 1397, 10.1007/s00345-014-1472-5 Bella, 2003, The prognostic significance of metastatic perivesical lymph nodes identified in radical cystectomy specimens for transitional cell carcinoma of the bladder, J Urol, 170, 2253, 10.1097/01.ju.0000095804.33714.ea Hu, 2014, Significance of perivesical lymph nodes in radical cystectomy for bladder cancer, Urol Oncol, 32, 1158, 10.1016/j.urolonc.2014.08.004 Stadler, 2002, Long-term survival in phase II trials of gemcitabine plus cisplatin for advanced transitional cell cancer, Urol Oncol, 7, 153, 10.1016/S1078-1439(02)00182-5 von der Maase, 2005, Long-term survival results of a randomized trial comparing gemcitabine plus cisplatin, with methotrexate, vinblastine, doxorubicin, plus cisplatin in patients with bladder cancer, J Clin Oncol, 23, 4602, 10.1200/JCO.2005.07.757 Bajorin, 1999, Long-term survival in metastatic transitional-cell carcinoma and prognostic factors predicting outcome of therapy, J Clin Oncol, 17, 3173, 10.1200/JCO.1999.17.10.3173 Apolo, 2013, Prognostic model for predicting survival of patients with metastatic urothelial cancer treated with cisplatin-based chemotherapy, J Natl Cancer Inst, 105, 499, 10.1093/jnci/djt015 Galsky, 2013, Nomogram for predicting survival in patients with unresectable and/or metastatic urothelial cancer who are treated with cisplatin-based chemotherapy, Cancer, 119, 3012, 10.1002/cncr.28146